drugset / Trial / NCT00467467

Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort

NCT00467467

Phase 3 Completed 60 enrolled University of Minnesota
RandomizedSingle-groupDouble-blind

Summary

To assess the impact of alfuzosin vs. placebo on ureteral stent discomfort, urinary symptoms and quality of life.

Timeline

Start
2006-06
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfuzosin Small molecule

Indications

No indication recorded.